cbdMDYCBD
About: cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
Employees: 42
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
41% more funds holding
Funds holding: 17 [Q4 2024] → 24 (+7) [Q1 2025]
22% more capital invested
Capital invested by funds: $69.3K [Q4 2024] → $84.4K (+$15.2K) [Q1 2025]
2.61% more ownership
Funds ownership: 3.34% [Q4 2024] → 5.95% (+2.61%) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Maxim Group Tom McGovern | 249%upside $3 | Buy Maintained | 22 May 2025 |
Financial journalist opinion









